or
forgot password
  • cancer clinical trials in charlottesville, VA

  • Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Lymphoma
    Screening and Diagnostic Trial to Compare the Effectiveness of Two Types of Mammography in Detecting Breast Cancer in Women
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Breast Cancer
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Leukemia
    Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Endometrial Cancer
    Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
    Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
    University of Virginia Cancer Center at UV Health System
    Charlottesville, Virginia 22908
    Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Lobradimil and Carboplatin in Treating Children With Brain Tumors
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Brain and Central Nervous System Tumors
    Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Leukemia
    Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Colorectal Cancer
    Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Sarcoma
    Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Sarcoma
    Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Colorectal Cancer
    Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Endometrial Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Pancreatic Cancer
    Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Prostate Cancer
    Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Extrahepatic Bile Duct Cancer, Liver Cancer
    Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Metastatic Cancer
    Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Colorectal Cancer, Neoplasm Metastasis
    Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Cervical Cancer
    Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Lung Cancer
    Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Cervical Cancer
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Martha Jefferson Hospital Cancer Care Center
    Charlottesville, Virginia 22901
    Lung Cancer
    Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Breast Cancer
    Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Leukemia, Myelodysplastic Syndromes
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Carcinoma of Unknown Primary
    Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Colorectal Cancer, Diarrhea, Neutropenia
    Clinical Trial for Ovarian Cancer (OvaRex®)
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Ovarian Cancer
    Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
    Hematology Oncology Patient Enterprises, Center for Cancer Care
    Charlottesville, Virginia 22902
    Non-small Cell Lung Cancer
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Malignant Mesothelioma
    Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Martha Jefferson Hospital Cancer Care Center
    Charlottesville, Virginia 22901
    Pancreatic Cancer
    Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Breast Cancer
    Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
    University of Virginia Cancer Center at UV Health System
    Charlottesville, Virginia 22908
    Cervical Cancer
    Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma
    University of Virginia Medical Center
    Charlottesville, Virginia 22908
    Non-Hodgkin's Lymphoma
    Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    University of Virginia
    Charlottesville, Virginia 22908
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Martha Jefferson Hospital Cancer Care Center
    Charlottesville, Virginia 22901
    Pancreatic Cancer
    SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
    Univ. of Virginia Health System-Cancer Center Clinical Trials Office
    Charlottesville, Virginia 22908
    Non-Hodgkin's Lymphoma
    Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
    Pain Management Center, University of Virginia
    Charlottesville, Virginia 22903
    Pain
    The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
    University of Virginia Health Systems - Department of Neurological Surgery
    Charlottesville, Virginia 22908
    Glioblastoma Multiforme
    A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care
    University of Virginia
    Charlottesville, Virginia 22908
    Carcinoma, Hepatocellular
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Endometrial Cancer
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
    University of Virginia Health Systems - Department of Neurological Surgery
    Charlottesville, Virginia 22908
    Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligoastrocytoma
    Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Glioblastoma Multiforme
    Adult-to-Adult Living Donor Liver Transplantation Study
    University of Virginia
    Charlottesville, Virginia 22908
    Cirrhosis, Hepatitis C, Hepatocellular Carcinoma
    Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Lymphoma
    Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Prostate Cancer
    Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    University of Virginia Cancer Center at UV Health System
    Charlottesville, Virginia 22908
    Head and Neck Cancer
    Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Lung Cancer
    Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Metastatic Cancer
    Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Sarcoma
    Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Breast Cancer, Osteoporosis
    Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Larynx, Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Verrucous Carcinoma of the Larynx, Stage IVA Verrucous Carcinoma of the Oral Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Larynx, Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Verrucous Carcinoma of the Larynx, Stage IVB Verrucous Carcinoma of the Oral Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Larynx, Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Oropharynx, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Verrucous Carcinoma of the Larynx, Stage IVC Verrucous Carcinoma of the Oral Cavity, Tongue Cancer
    Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)
    University of Virgina Cancer Center, UVA Division of Hematology & Oncology
    Charlottesville, Virginia 22908
    Leukemia, Myeloid, Chronic Phase